Literature DB >> 10618066

Characterization of Streptococcus agalactiae isolates of bovine and human origin by randomly amplified polymorphic DNA analysis.

G Martinez1, J Harel, R Higgins, S Lacouture, D Daignault, M Gottschalk.   

Abstract

Streptococcus agalactiae is considered one of the major causes of bovine intramammary infections. It is also found in the vaginas of women without any apparent clinical symptoms, but reports of neonatal infections, causing significant morbidity, are relatively frequent. The aim of this study was to evaluate the genetic diversity of S. agalactiae strains isolated from bovine milk and from asymptomatic women in Québec, Canada, by randomly amplified polymorphic DNA (RAPD) analysis. A total of 185 bovine isolates and 38 human isolates were first serotyped for capsular polysaccharide by double diffusion in agarose gel (bovine isolates) and coagglutination (human isolates). Strains were then studied by RAPD using 3 primers, designated OPS11, OPB17, and OPB18, which were selected from 12 primers. Thirty-eight percent of bovine isolates and 82% of human isolates could be serotyped. Prevalent serotypes were type III (28%) for bovine isolates and types V (26%) and III (24%) for human isolates. RAPD results showed that, taken together, all isolates (of bovine and human origin) shared 58% similarity. Ninety-four percent of these isolates were clustered in four groups (I, II, III, and IV) with 70% similarity among them. Three clusters, A (48 isolates), B (14 isolates), and C (32 isolates), with 79 to 80% similarity were identified within group IV, whereas the three other groups did not present any clusters. Despite some clustering of human isolates, relatively high diversity was seen among them. Relatively high heterogeneity was observed with the RAPD profiles, not only for field strains belonging to different serotypes but also for those within a given serotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618066      PMCID: PMC86023          DOI: 10.1128/JCM.38.1.71-78.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Authors:  J G Williams; A R Kubelik; K J Livak; J A Rafalski; S V Tingey
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

Review 2.  Streptococcal ecovars associated with different animal species: epidemiological significance of serogroups and biotypes.

Authors:  L A Devriese
Journal:  J Appl Bacteriol       Date:  1991-12

3.  Genetic diversity of rRNA operons of unrelated Streptococcus agalactiae strains isolated from cerebrospinal fluid of neonates suffering from meningitis.

Authors:  S Chatellier; H Huet; S Kenzi; A Rosenau; P Geslin; R Quentin
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

4.  Epidemiological aspects of group B streptococci of bovine and human origin.

Authors:  N E Jensen; F M Aarestrup
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

5.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 6.  Group B streptococcus (S. agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature.

Authors:  P I Lerner; K V Gopalakrishna; E Wolinsky; M C McHenry; J S Tan; M Rosenthal
Journal:  Medicine (Baltimore)       Date:  1977-11       Impact factor: 1.889

7.  Clinical mastitis in dairy cattle in Ontario: frequency of occurrence and bacteriological isolates.

Authors:  J M Sargeant; H M Scott; K E Leslie; M J Ireland; A Bashiri
Journal:  Can Vet J       Date:  1998-01       Impact factor: 1.008

8.  Molecular epidemiology of group B streptococcal infections: use of restriction endonuclease analysis of chromosomal DNA and DNA restriction fragment length polymorphisms of ribosomal RNA genes (ribotyping).

Authors:  H M Blumberg; D S Stephens; C Licitra; N Pigott; R Facklam; B Swaminathan; I K Wachsmuth
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

9.  Ribotyping of Streptococcus agalactiae strains isolated from vaginas of asymptomatic women.

Authors:  H Huet; C Martin; P Geslin; F Grimont; R Quentin
Journal:  Res Microbiol       Date:  1993 Jul-Aug       Impact factor: 3.992

10.  Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease.

Authors:  R Quentin; H Huet; F S Wang; P Geslin; A Goudeau; R K Selander
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more
  26 in total

1.  Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources.

Authors:  Rafael S Duarte; Bruna C Bellei; Otávio P Miranda; Maria A V P Brito; Lúcia M Teixeira
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.

Authors:  John F Bohnsack; April Whiting; Marcelo Gottschalk; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; George G Rhoads; Feng-Ying C Lin
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

3.  Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population.

Authors:  Roberto Rosini; Edmondo Campisi; Matteo De Chiara; Hervé Tettelin; Daniela Rinaudo; Chiara Toniolo; Matteo Metruccio; Silvia Guidotti; Uffe B Skov Sørensen; Mogens Kilian; Mario Ramirez; Robert Janulczyk; Claudio Donati; Guido Grandi; Immaculada Margarit
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

4.  Molecular subtyping and characterization of bovine and human Streptococcus agalactiae isolates.

Authors:  Sharinne Sukhnanand; Belgin Dogan; Maranatha O Ayodele; Ruth N Zadoks; Mary Patricia J Craver; Nellie B Dumas; Ynte H Schukken; Kathryn J Boor; Martin Wiedmann
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.

Authors:  Fanrong Kong; Lotte Munch Lambertsen; Hans-Christian Slotved; Danny Ko; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

6.  Molecular fingerprinting of fish-pathogenic Lactococcus garvieae strains by random amplified polymorphic DNA analysis.

Authors:  Carmen Ravelo; Beatriz Magariños; Sonia López-Romalde; Alicia E Toranzo; Jesús L Romalde
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Emergence and global dissemination of host-specific Streptococcus agalactiae clones.

Authors:  Uffe B Skov Sørensen; Knud Poulsen; Claudia Ghezzo; Immaculada Margarit; Mogens Kilian
Journal:  MBio       Date:  2010-08-24       Impact factor: 7.867

8.  Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor.

Authors:  Naiel Bisharat; Derrick W Crook; James Leigh; Rosalind M Harding; Phil N Ward; Tracey J Coffey; Martin C Maiden; Tim Peto; Nicola Jones
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci.

Authors:  A Dmitriev; E Shakleina; L Tkáciková; I Mikula; A Totolian
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

10.  Association of Group B Streptococcus colonization and bovine exposure: a prospective cross-sectional cohort study.

Authors:  Shannon D Manning; A Cody Springman; Amber D Million; Nicole R Milton; Sara E McNamara; Patricia A Somsel; Paul Bartlett; H Dele Davies
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.